Szczepienia, a choroby u dzieci – prof. Maria Dorota Majewska

Posted on 30 stycznia 2011. Filed under: autyzm, dzieci, pdf, prof maria dorota majewska, zagrożenia szczepieniami | Tagi: , , , , , , , |

Wielu z Was zastanawiało się czy szczepić swoje pociechy czy nie. Każdy rodzic musi podjąć tą decyzję indywidualnie. My jedynie możemy państwu pomóc w podjęciu właściwego wyboru.
Każdy z nas pamięta osobę pani profesor nauk medycznych doktor habilitowaną Marię Dorotę Czajkowską-Majewską.

To właśnie tej osobie zawdzięczamy wstrzymanie się rządu RP przed zakupem trującej chemii w szepionkach na wirus AH1N1 dla Polaków.
Jako pierwsi zamieszczamy artykuł pani profesor i wyniki jej badań na temat szczepień u dzieci.

Jesteśmy świadomi, że media masowej manipulacji takie jak tvn, tvn24 czy polsat i wyborcza nigdy tego nie przedstawią… z oczywistych względów.

My to jednak robimy bo życie ludzkie cenimy bardziej niż zysk czy układy.

Wpływ szczepień na autyzm u dzieci – plik pdf

Read Full Post | Make a Comment ( None so far )

Ayurweda zagrożona wytycznymi kodeksu żywnościowego

Posted on 25 grudnia 2010. Filed under: ANH, ANH fight for true, ANH walka o prawdę, kodeks żywnościowy, leczenie ziołami, medycyna alternatywna, medycyna chińska, medycyna mongolska, medycyna naturalna | Tagi: , , , , , |

India recognises risks to Ayurveda from Europe


4th World Ayurveda Congress
Venue: Gayathri Vihar, Palace Grounds, Bengaluru, Karnataka, India
9-13 December 2010

Around 5,000 practitioners, manufacturers, distributors and interested consumers converged on the Palace Grounds in Bengaluru, India last week.  Progressing the mission of “Ayurveda for All”, the biannual 4th World Ayurveda Congress (4th WAC) hosted an impressive and comprehensive range of keynote and plenary sessions relating to the philosophy of Ayurveda.

While much of the meeting focused on recent progress on the scientific validation and development of Ayurveda, an additional and important strand running through the meeting was the ‘globalisation’ of Ayurveda. This included detailed exploration of both the opportunities and the challenges facing Ayurveda outside its native heartland in the Indian subcontinent. It was in this latter context that ANH-Intl executive and scientific director, Dr Robert Verkerk, was invited to give one of the keynote lectures.

Main Hall, 4th World Ayurveda Congress, Palace Grounds, Bengaluru

Background to Ayurveda

The word Ayurveda is made up from two Sanskrit words—‘ayus’ meaning life and ‘veda’ meaning knowledge or science.  Simply put, Ayurveda can be described as the ‘science or knowledge of life’, which the early scholars understood to comprise the mind, body, senses and soul.  A view which is little changed today.  Professor Savrikar from Podar Medical College in Mumbai agreed that “unless a person is very happy mentally we can’t say he’s healthy”.  Hence it is not simply a traditional system of medicine, but more a complete philosophy for life.  Ayurveda encompasses a wide range of modalities including yoga, meditation, nutrition, detoxification, massage and the use of herb and mineral preparations.  The fundamentals of Ayurveda were laid down in Vedic scripts, the earliest of which, the Rig Veda, dates back 6,000 years and contains a number of ‘prescriptions’ to help overcome various ailments.  The aim of Ayurveda is to promote health and prolong life and in so doing eliminate disease and dysfunction.  The key to success involves focusing more on prevention, rather than cure, and by restoring and maintaining balance of body, mind and spirit.

Sadly in the West this body/mind/spirit balance is poorly understood by government regulators and allopathy in general.  So too are traditional medicinal cultures that are not purely concerned with the treatment and cure of disease.  The result being a situation such as the one in Europe, where this valuable tradition is being ripped apart into its component parts, legislated by different laws and inappropriately judged against the same pharmaceutical standards used for new-to-nature drugs.  Western medicine and pharmaceuticals have been around for a relative split-second in time compared to ancient traditions such as Ayurveda and Traditional Chinese Medicine.

The arrogance and ignorance that appears to be shown by the European Commission and EU Member State regulators is one of the greatest travesties of our time, earning Europe the label “the dark continent for Ayurveda” by Dr Prasad from Himalaya Herbal Healthcare.  To decimate these traditions, to uphold wrongly that there is no scientific basis to their effectiveness and then to deny innovation (i.e. their continued development) is to deprive European citizens of a fundamental and basic right to health and freedom of choice.  Let alone maintain the vast tradition for future generations in Europe, one that is so well established to counter to massive burden of chronic disease which allopathic medicine is barely denting.

In India, where there is exponential growth in the generic pharmaceutical industry, there is still great confidence in the national tradition of Ayurveda.  Faced with 30 million diabetics, 100 million with cardiovascular disease and 30% of children being born of low birth weight, figures set to increase alarmingly by 2030, Ayurveda offers a low-cost, health-for-all solution.  This rapid growth in chronic diseases can be attributed largely to the substitution of traditional diets and lifestyles with western ones. Academics and Ayurvedic physicians are working together to re-instate a sustainable healthcare system that empowers the individual and is affordable for all.  Despite the number of pharma companies lured to India by the promise of cheap labour and reduced overheads, western medicine will never be in a position to offer both a healthcare system and a viable economy for the people.  In contrast, Ayurveda is not just a disease management system, but a way of life that promotes health, empowers the mind and spirit and, through herbal cultivation, offers financial sustainability too.

Despite gilding the bitter European regulatory lily in the colours of consumer protection, it’s clear that we’re again dealing with profits over people.  We hope you’ll take action to safeguard our traditional systems of medicine and join the campaign.

4th WAC

Dr Robert Verkerk, chaired and gave the keynote address in the first of two sessions entitled ‘Globalisation of Ayurveda and IPR’.  His presentation outlined the current challenges facing on Ayurveda through impending legislation in Europe.  The Traditional Herbal Medicinal Products Directive (THMPD) poses a significant hurdle for many manufactured products from traditional herbal medicinal disciplines.

Dr Robert Verkerk ANH-Intl, keynote presentation, 4th World Ayurveda Congress, Bengaluru

Similar sentiments were echoed amongst the visiting dignitaries, doctors and academics to the Congress.  A selection of which follow:

“Prevention is better than cure”
“There will be no need for treatment if you use and live the principles of Ayurveda”
“Let us take Ayurveda to the top and have it not just our national pride, but our national health too”
“We have a habit of running with short-term solutions.  We need to look for long-term solutions. Ayurveda is here to stay.  We have a bright future for Indian medicine in India and the rest of the World”

Dr Verkerk appealed to the large audience to become proactive. In communicating his concern over the slowness of response by practitioners and companies involved in the Europe, he made an analogy: He said that it seemed many were sitting on deck chairs admiring the wonders of the ocean, and even after hearing that a tidal wave was due, they still sat enjoying their comfort.

Key connections were made and it seems that most leading players were still not ready to face the reality that is being presented to Ayurvedic suppliers and non-medical practitioners in Europe. Conversely, it was also clear that a few high ranked officials were very aware of the problems and were keen to see all avenues followed to help allow Ayurveda to flourish in Europe, as well as elsewhere in the world.

International Meeting

The 4th WAC was preceded by a 2-day International Delegates Assembly (IDA), held at His Holiness Sri Sri Ravishankar Ji’s ashram—the Art of Living Foundation—on the Kanakpura road outside Bengaluru.

Art of Living Foundation, Bengaluru, India

The IDA was hosted by the Indian government Department of AYUSH (Ayurveda, Unani, Siddha and Homeopathy), and was opened by Dr SK Sharma, advisor to AYUSH.  There are now 260 Ayurvedic medical colleges offering degrees and post-graduate courses in India to 15,000 students.  Traditionally trained doctors number 7.5 million, their practices being served by 10,000 manufacturing units.  After 4 years of debate with the European Commission over the THMPD, the Indian Government has made little headway.  With full implementation due in May 2011, Dr Sharma argued that this legislation “is not of a scientific nature, but of a trade and political nature”.

Along with around 200 invited international delegates, Dr Rob Verkerk along with Meleni Aldridge, executive coordinator, attended on behalf of ANH-Intl.  Under the theme of ‘global recognition of Ayurveda’ dignatories and delegates outlined the advances in the practice, teaching and awareness of Ayurveda from different parts of the world.  Unfortunately, there still seem to be many in the global Ayurvedic community still unaware of the travesty taking place in Europe.  Rob Verkerk’s presentation entitled “Why urgent regulatory change is needed in Europe to safeguard the future of Ayurveda” sought to change that.

Opening ceremony at the International Delegate Assembly, Art of Living Foundation, Bengaluru, India

Further discussions focussed on the dissemination of Ayurveda globally.  Passion for this ancient holistic, lifestyle approach, that is so much more than a system of medicine, was palpable throughout.  It was refreshing to be amongst such positivity and enthusiasm and in such a tranquil setting as the Art of Living Foundation.  His Holiness Sri Sri Ravi Shankar welcomed the delegates and described how Ayurveda was again becoming central to their work in the poorest communities in India.  Volunteers from the Foundation have initiated a programme of teaching the necessary skills needed to help villagers to once again grow traditional herbal plants.  He urged us all to follow this lead internationally to safeguard the vulnerable traditional botanical species, which are most at risk of extinction through over collection.  This simple, cost-effective and sustainable strategy is proving very successful in reducing drug and alcohol addiction and improving health in the villages.

His Holiness Sri Sri Ravi Shankar, Founder, Art of Living Foundation, Bengaluru, India

International delegates and government officials alike shared their personal journeys and experiences of Ayurveda.  Common to all was the immeasurable respect and inherent responsibility synonymous with accepting guardianship of such a precious and ancient philosophy.  That European legislation, in its arrogance and ignorance, may signal an end to traditional medicinal cultures is something we all need to take responsibility for preventing.  Even as western healthcare systems buckle under the spiralling costs of drug-based allopathy, governments, strongly lobbied by pharma cartels, are set to severely handicap our access to preventative healthcare—unless we stand up for our rights.  As Dr Gerry Bodekar, from the department of Medical Sciences, Oxford University reminded us, “there’s nothing alternative about so-called alternative medicine.  Modern medicine could be considered alternative in some parts of the world”.

Dr Gerry Bodekar, Department of Medical Sciences, Oxford University

Without widespread civil action, even disobedience, we are in danger, particularly in Europe, of losing the last vestiges of control over our own health.  A diseased society equals increased profits for the drug industry.  Disease prevention through complementary and alternative medicine is bad for business.  An oft-repeated phrase during the 4th WAC was that there will be no need for treatment if you use and live the principles of Ayurveda.  Health prevention is sustainable—treatment based on western drug-based medicine is not.  The stranglehold that has developed by large corporations over our healthcare, food and energy industries must be broken.  Our health is a basic birthright and traditional medicinal cultures like Ayurveda, Unani, Traditional Chinese Medicine, etc have a huge amount to offer.  At the very least, the choice should be ours.

To avoid becoming another sacrificial lamb on the altar of Big Pharma profits, and to become an active participant in safeguarding the future of traditional herbal medicine in Europe, visit our THMPD campaign.


ANH-Europe homepage
Nurture Traditional Medicinal Cultures campaign page

Read Full Post | Make a Comment ( None so far )

Naciski na ustawodawców Unii Europejskie w sprawie ziołowych preparatów medycyny chińskiej i medycyny indyjskiej

Posted on 4 września 2010. Filed under: chińska medycyna, codex alimentarius, dr Enji, enji, gabinet medycyny naturalnej, kodeks żywnościowy, lekarka mongolska, lekarz Enji, lekarz Enkhjargal Dovchin, medycyna chińska, medycyna mongolska, tradycyjan medycyna chińska, zioła chińskie | Tagi: , , , , , , , , |

Press Release
For immediate release

1st September 2010

Two leading European groups unite to help re-shape legal frameworks around Chinese and Indian herbal products

Download as a pdf

BRUSSELS, 1 Sep 10. The European Benefyt Foundation and the Alliance for Natural Health International (ANH-Intl) presented yesterday their united strategy to a range of stakeholders representing Chinese and Ayurvedic traditions of herbal medicines. The meeting was held in the Renaissance Hotel, Brussels.

The proposed strategy aims in particular to address the grave regulatory situation facing thousands of products representing non-European herb-based healthcare traditions. It will also help to keep on the market products associated with minor European herbal traditions that are struggling to cope with the raft of EU laws affecting them.

In April 2011, when the EU Traditional Herbal Medicinal Products Directive (THMPD) is fully implemented after a seven year transition phase, thousands of products distributed by specialist herbal suppliers will become increasingly difficult to sell. Medicines regulators in many Member States appear to be using the full implementation of the THMPD as a means of narrowing the scope of the food supplements regime, under which most of these products have to-date been sold. The long transition phase of the THMPD is meant to have provided stakeholders with the time required to ensure their products have been successfully registered under the simplified medicinal licensing scheme offered by the Directive.

However, a range of eligibility and technical problems, along with prohibitive costs, have, so far, prevented any products from either the Chinese or Indian traditions from successfully being registered under the scheme.

The core strategy of the two organisations has been detailed in a 10-page position paper authored by the heads of the respective organisations, namely Dr Robert Verkerk (ANH-Intl) and Chris Dhaenens (Benefyt). The paper was tabled at the stakeholders meeting and received broad support from the diverse range of attendees, some of which had travelled from as far away as India.

The joint strategy was presented at the conference by lead author, Dr Verkerk. Commenting on it, he said, “While the herbal directive provides an additional framework that is amenable to some, predominantly European herbal products, it simply doesn’t work for the majority of complex, multi-herb products associated with these ancient non-European traditions.”

The strategy involves three primary initiatives; improvement of the food supplements regime under which most Chinese and Indian herbal products have been sold up until now, the initiation of judicial review proceedings with the aim of gaining a reference to the European Court of Justice, and the development of an altogether new framework for such products. The former two approaches are regarded as essential to the short-term resolution of challenges facing many stakeholders as of mid-2011, while the latter focuses on facilitation of a new framework that is both accessible to the majority of stakeholders in the sector, whilst ensuring the safety of products through proportionate and scientifically-validated quality control measures.

Verkerk added, “We have seen a big increase in classifications by national medicine regulators of herbs as novel foods or unlicensed medicines, and it is clear that regulators intend to narrow the scope of the food supplement regime for herbal products after April next year. On top of this, most claims for botanical food supplements will soon have to be removed given the anticipated negative opinions being issued by the European Food Safety Authority under Article 13 of the Nutrition and Health Claims Regulation. The herbal directive, which should provide a carve out for these products, acts disproportionately against non-European traditions, while also discriminating against those who want to use such products—that have after all stood the test of time—to manage their own health. It is therefore essential that judicial review proceedings are started in advance of the end of the transition period.”

Speaking after the conference, Chris Dhaenens said, “The herbal directive as it currently stands is poorly thought through and is simply inaccessible to most players distributing high quality Chinese or Indian herbal products in Europe. Ironically, while the quality control measures are one of the biggest stumbling blocks for most stakeholders in the sector, they don’t guarantee that products are safe. Amongst our proposals, are revised quality control measures that are both cheaper and more effective than those offered by the existing directive. We are very happy to be collaborating closely with the ANH and are hopeful that a strong, more united effort will bring positive change.”

Download the joint ANH/Benefyt position paper.

ANH-Intl and Benefyt are calling on interested parties to contact either of the organisations for further information. They have stressed that adequate financial support will be crucial to the effective implementation of the joint strategy and have warned that inaction will result in the loss of thousands of products with consequent impacts both on public health and the small businesses in the sector.



For further information, please contact:

ANH-Intl: Sophie Middleton (campaign administrator), tel +44(0)1306 646 600 or email

European Benefyt Foundation: Chris Dhaenens or Harrie Sandhövel, Tel +31 320 251 313 or email:


ANH-Benefyt position paper

Position paper title: Working collaboratively to maintain the supply of products associated with traditional systems of medicine in Europe from 2011 onwards

About ANH International

Alliance for Natural Health International is an internationally active non-governmental organisation working towards protecting and promoting natural approaches to healthcare. ANH-Intl campaigns across a wide range of fields, including for freedom of choice and the use of micronutrients and herbal products in healthcare. It also operates campaigns that aim to restrict mass fluoridation of water supplies and the use of genetically modified foods. Through its work particularly in Europe ( and the USA (, the ANH works to accomplish its mission through its unique application of ‘good science’ and ‘good law’. The organisation was founded in 2002 by Dr Robert Verkerk, an internationally acclaimed expert in sustainability, who has headed the organisation since this time. The ANH brought a case against the European directive on food supplements in 2003, which was successfully referred to the European Court of Justice in early 2004. The ruling in 2005 provided significant clarification to areas of EU law affecting food supplements that were previously non-transparent.

About the European Benefyt Foundation

EBF is the result of the merging interests and concerns of two parties: The Belgian professional association O.P.P.As (Oriental Plant Promotion Association) and two Dutch operators in the field of Ayurveda. Together we have monitored the evolution and the interpretation of EU and national legislation in the past few years. We have come to the conclusion that under this legislation traditional disciplines will either be exterminated or else will survive as a ludricrous caricature of the original. As far as we are concerned, under the actual directives, the EU regulatory authorities are throwing the baby away with the bathwater. We will try, in an open dialogue with our partners, to develop viable alternatives to preserve those systems in the CAM healthcare landscape in the EU.

About the Traditional Herbal Medicinal Products Directive (THMPD)

For further information about the EU directive on traditional herbal medicines (THMPD) and concerns over its implementation, please download the following ANH briefing paper:

Więcej informacji:

Medycyna Tybetańsko-Mongolska

prof. Enkhjargal Dovchin

Read Full Post | Make a Comment ( None so far )

Rząd puści z torbami zielarzy

Posted on 3 kwietnia 2010. Filed under: codex alimentarius, dr Enji, enji, lekarz Enji, lekarz Enkhjargal Dovchin, lex nostrum | Tagi: , , , , , |

Autor: Wiktor Ferfecki
Minister Zdrowia Ewa Kopacz wydała rozporządzenie ograniczające liczbę produktów, które mogą być sprzedawane w sklepach zielarsko-medycznych – dowiedział się portal Właściciele obawiają się, że sklepom grozi plajta, bo zakazano im sprzedaży rutinoscrobinu, witaminy C i maści borowinowej
Minister Ewa Kopacz wydała rozporządzenie, które – zdaniem  zielarzy – skazuje ich sklepy na plajtę (Fot. PAP/Tomasz Gzell

Minister Ewa Kopacz wydała rozporządzenie, które – zdaniem zielarzy – skazuje ich sklepy na plajtę (Fot. PAP/Tomasz Gzell

Rozporządzenie weszło z życie w październiku. Sklepy zielarskie mogą sprzedawać zapasy zakazanych produktów do marca. – Musimy wycofać z obrotu ponad tysiąc rodzajów produktów – informuje Ryszard Zaremba z Polskiej Izby Zielarsko-Medycznej i Drogeryjnej. – Uważamy, że rozporządzenie ministra zdrowia ma nas charakter krzywdzący i dyskryminacyjny – podkreśla.

Po wyczerpaniu się zapasów zielarze nie będą mogli już handlować tak popularnymi lekami, jak rutinoscorbin, witamina C, pasta cynkowa i jodyna. Z obrotu będą musieli też wycofać wiele znanych ziół i produktów leczniczych, w tym olej rycynowy, olejek kamforowy, białą wazelinę, sól bocheńską i maść borowinową. – Nasi klienci nie są w stanie zrozumieć, dlaczego niektórych leków nie mogą kupić u nas, a preparaty o niemal identycznym składzie są dostępne na stacjach benzynowych. W zmian za to dopuszczono leki, które powinny być sprzedawany tylko w aptekach – wyjaśnia Ryszard Zaremba.

Jak Ministerstwo Zdrowia tłumaczy konieczność zmian? – Rozporządzenie wymagało nowelizacji, bo na rynku przybywa zarejestrowanych produktów leczniczych i lista musi być aktualizowana – mówi Piotr Olechno, rzecznik Ewy Kopacz. – Przyznaję, że wkradły się pewne błędy. Dlatego jesteśmy w kontakcie ze środowiskiem punktów aptecznych i sklepów zielarsko-medycznych. Wspólnie pracujemy nad kolejną nowelizacja rozporządzenia – dodaje.

Zielarze mają jednak do rządu ograniczone zaufanie. W grudniu na stronach internetowych ministerstwa pojawiła się kolejna propozycja listy produktów, równie kontrowersyjna, co poprzednia. – Aktualizacja okroiła nam listę o produkuty, którymi głównym składnikami jest waleriana, miłorząb japoński i żeń-szeń. W zamian za to pojawiły się leki dostępne tylko na receptę – informuje Zaremba. – Ewa Kopacz nie śpieszy się ze znowelizowaniem krzywdzącego rozporządzenia, choć przed dwoma laty w szybkim trybie uchyliła rozporządzenie ministra Zbigniewa Religii – dodaje.

W obronę interesów zielarzy włączyła się Komisja „Przyjazne Państwo”. Ich sprawie było poświęcone jedno z jej posiedzeń. – W czwartek skierowaliśmy do ministra zdrowia dezyderat w sprawie zielarzy. Prosimy o wyjaśnienie, dlaczego ze sklepów wycofano popularne produkty, a na liście są błędy – informuje wiceprzewodnicząca komisji Hanna Zdanowska z PO.

Read Full Post | Make a Comment ( None so far )

Ayurweda zagrożona – lek. Enji

Posted on 1 kwietnia 2010. Filed under: ANH, ANH fight for true, ANH walka o prawdę, codex alimentarius, dr Enji, enji, lekarz Enji, lekarz Enkhjargal Dovchin | Tagi: , , |

Ayurveda drugs face scrutiny abroad R. Ramabhadran Pillai

European Union’s new regulations will come into force after March 2011.

KOCHI: The exporters of Ayurvedic products to the European Union (EU) will have to follow the new regulations adopted by the EU, which would come into force after March 2011.

It would be imperative on the part of exporters to adhere to the norms, said B. Anand, Joint Secretary, Department of Ayush, Ministry of Health & Family Welfare, Government of India. He was talking to newspersons here on Friday at the Global Ayurveda Summit, organised by CII and Ayush.

The Traditional Herbal Medicinal Products (THMP) directive would restrict the export of medicinal herb products through fresh norms. A THMP registration or marketing authorisation would be required for marketing the products after March 2011.

The products would have to be certified after undergoing a systematic process of verification which might incur high costs to the Indian manufacturer. Herbal products, traditionally marketed in the EU for 30 years, could be registered with a dossier showing quality data and ingredients which would have to be approved by the EU authorities.

Ayush is teaming up with the Quality Council of India to register herbal products and already 35 products of various companies have been listed for registration, he said. It has devised special courses for the international medical community. Some foreign universities have adopted Ayurvedic courses. Three institutions, in UK, Germany and the US, have tied up with Ayush for launching courses in Ayurveda.

Earlier, Mr. Anand said Ayurveda is the most widely recognised traditional system of Indian medicine in the global context. It is known as Complementary and Alternative Medicine or Traditional Medicine under the system adopted by World Health Organisation.

The WHO provides brief information on the challenges faced by traditional medicine worldwide. It also gives messages and a check-list for the safety, efficacy and quality to policy-makers. Ayush is undertaking a multi-pronged, integrated and comprehensive set of activities for promoting quality education, research, standardisation of drugs and quality assurance, he said.

Printer friendly page
Send this article to Friends by E-Mail


Nowe regulacje UE doprowadzą do całkowitego zakazu i ścigania ludzi zajmujących się szeroko pojętą medycyną naturalną. Jest to próba przejęcia całkowitej kontroli nad suplementami diety i produktami tradycyjnej medycyny danych krajów, a w szczególności CHIN, TYBETU, MONGOLII. Mamy nadzieję, że społeczeństwo wyrazi swoje zdanie oddając głos w petycji na rzecz referendum w obronie medycyny naturalnej.

Read Full Post | Make a Comment ( 4 Komentarze )

  • Google Translator

  • STOP kłamstwu tvn!

    STOP TVN, TVN24, POLSAT I WYBIÓRCZEJ - stop zakłamaniu w mediach masowych
  • Chroń medycynę naturalną/ Protect natural medicine all over the world
  • Podpisz petycję w obronie medycyny naturalnej i tradycyjnych systemów medycznych
  • Medycyna Tybetańsko-Mongolska, Akupunktura, Moksa, Ziołolecznictwo na PINTEREST.COM
  • Polub nas na FB

  • Artykuł o nagonce

  • Czwarty Wymiar o nagonce medialnej

    Artykuł w "CZWARTYM WYMIARZE" o nagonce medialnej na lekarkę Enkhjargal Dovchin "ENJI"
  • Artykuły w „ZC”

    Znaki Czasu - to obecnie jedyne czasopismo, które ma odwagę pisać jawnie o najważniejszych sprawach dotyczących zdrowia ludzkiego czyli Kodeksie Żywnościowym, Szczepieniach oraz alternatywnych metodach leczniczych.
  • MTM in Poland

    Mongolska Tradycyjna Medycyna w Polsce - MTM in Poland

  • Chmurka kategorii

  • Ankiety

  • Szybkie menu

Liked it here?
Why not try sites on the blogroll...